Hungary Country Drug Report 2019
Hungary
Country Drug Report 2019
About this report
Sections
What are the long-term aims of drug policy in Hungary? How are these aims to be achieved? How is drug policy coordinated at national level?
Learn moreUnderstanding the costs of drug-related actions is an important aspect of policy evaluation.
Learn moreWhat substances and activities does Hungary control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?
Learn moreHow many people in Hungary have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?
Learn moreWhat are the main infectious diseases linked to drug injecting in Hungary?
Learn moreHow many people died of drug overdoses or poisonings in Hungary in the last year?
Learn moreWhat part does prevention play in Hungary drug strategy. What are the main prevention approaches used in the country and who do they target?
Learn moreHow does Hungary measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.
Learn moreHow is the drug treatment system organised in Hungary? How is it financed? How is the provision of treatment divided between inpatient and outpatient settings?
Which authorities are responsible for prison health in Hungary? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
What is done in Hungary to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?
In which areas of study is drug-related research carried out in Hungary? How is this research funded? Are any types of research emphasised in the national drug strategy?
What is known about drug supply and trafficking in Hungary? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?
Learn morePartners
About our partner in Hungary
The Hungarian national focal point has been located within the National Institute for Health Development since 1 January 2016. Its legal basis was confirmed by an adoption of a governmental resolution in September 2003. The Inter-ministerial Coordination Committee on Drug Affairs oversees the work of the national focal point.
Hungarian national focal point
Ministry of Human Capacities
Deputy State Secretariat for the Chief Medical Officer’s Affairs
Department for Health Development and Screening Coordination
Unit for Focal Points of Addictions
Albert Flórián str. 2-6
H-1097 Budapest, Hungary
Tel. +36 1 476 11 00
Head of national focal point: Mr Gergely Horváth
Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.